Previous studies identified peptides from annexin A2, apolipoprotein B-100, thymidine phosphorylase (endothelial cell growth factor), and stromelysin-2 (matrix metalloproteinase 10) as targets of autoreactive T cells in a subset of human Lyme disease patients (22–24). This evidence concerns the gene APOB and Lyme disease.